Prosecution Insights
Last updated: November 06, 2026
Application No. 19/053,064

SYSTEMS AND METHODS FOR AUTONOMOUS STERILIZATION

Non-Final OA §102§DOUBLEPATENT
Filed
Feb 13, 2025
Priority
Apr 15, 2020 — provisional 63/010,475 +3 more
Examiner
CHORBAJI, MONZER R
Art Unit
1799
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Robotic Research LLC
OA Round
1 (Non-Final)
76%
Grant Probability
Favorable
1-2
OA Rounds
10m
Est. Remaining
98%
With Interview

Examiner Intelligence

Grants 76% — above average
76%
Career Allowance Rate
932 granted / 1221 resolved
+11.3% vs TC avg
Strong +21% interview lift
Without
With
+21.3%
Interview Lift
resolved cases with interview
Typical timeline
2y 6m
Avg Prosecution
36 currently pending
Career history
1259
Total Applications
across all art units

Statute-Specific Performance

§101
2.6%
-37.4% vs TC avg
§103
46.3%
+6.3% vs TC avg
§102
36.0%
-4.0% vs TC avg
§112
11.0%
-29.0% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1221 resolved cases

Office Action

§102 §DOUBLEPATENT
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA This is a first action on the merits for this continuous application filed on 02/13/2025 Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claims 1-11 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Flaherty et al. (US 2012/0223216 A1). Regarding claim 1, Flaherty et al. discloses an autonomous sanitizing system (Fig.1A:10), comprising: one or more processors (Fig.1C:110); one or more sensors (Fig.3:90) in communication with the one or more processors; one or more sanitizing devices (Fig.1D:61 and 62) in communication with the one or more processors and configured to deliver one or more sanitizing treatments [0133]; a non-transitory memory [0007] coupled to the one or more processors and storing instructions, which when executed by the one or more processors, implements actions comprising: determining whether a sanitizing trigger is satisfied at a given location [0011-0013]; detecting, with the one or more sensors, an exception condition associated with the given location [0009]; identifying [0010], based at least in part on the exception condition, a select sanitizing treatment of the one or more sanitizing treatments [0012]; actuating the one or more sanitizing devices to deliver the select sanitizing treatment at the given location [0012 and 0133-0138]; a non-transitory memory [0007] coupled to the one or more processors and storing instructions, which when executed by the one or more processors, implements actions comprising: detecting, with the one or more sensors [0007], one or more objects within the given location; classifying the one or more objects [0007]; selecting [0010], based at least in part on classification of the one or more objects, a select sanitizing treatment; and delivering, with the one or more sanitizing devices, the select sanitizing treatment at the given location [0012 and 0133-0138]. Regarding claim 3, Flaherty et al. system is capable of selecting [0130] sanitizing treatment includes switching from a first sanitizing treatment of the one or more sanitizing devices to a second sanitizing treatment of the one or more sanitizing devices. Regarding claim 4, Flaherty et al. is capable of [0132] classifying the one or more objects comprises identifying a living object, a mobile object and/or a stationary object. Regarding claim 5, Flaherty et al. discloses actuating [0010] the one or more sanitizing devices to deliver the select sanitizing treatment at the given location includes initiating the select sanitizing treatment upon exit of the living object or the mobile object from the given location. Regarding claim 6, Flaherty et al. discloses that the one or more sensors [0007] comprises at least one of a LiDAR device, a radar device, a PIR device, an acoustic ranging device, a pressure sensor, and a temperature sensor. Regarding claim 7, Flaherty et al. discloses that delivering, with the one or more sanitizing devices (Fig.3:90, 61, and 62) , the select sanitizing treatment at the given location includes directing emissions of the select sanitizing treatment toward a first object of the one or more objects and limiting emissions of the select sanitizing treatment toward a second object of the one or more objects. Regarding claim 8, Flaherty et al. discloses that the one or more sanitizing devices are mounted (Fig.3:20 and 61-62) to an autonomous vehicle. Regarding claim 9, Flaherty et al. discloses that the one or more sensors (Fig.3:20 and 90) are mounted to the autonomous vehicle. Regarding claim 10, Flaherty et al. discloses that the instructions, which when executed by the one or more processors [00070022], implements further actions comprising: outputting notifications with one or more output devices in association with the select sanitizing treatment. Regarding claim 11, Flaherty et al. discloses that the one or more sanitizing devices includes one of a chemical emission device or one of an ultraviolet light emission device (Fig.3:61-62). Double Patenting The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969). A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA as explained in MPEP § 2159. See MPEP § 2146 et seq. for applications not subject to examination under the first inventor to file provisions of the AIA . A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b). The filing of a terminal disclaimer by itself is not a complete reply to a nonstatutory double patenting (NSDP) rejection. A complete reply requires that the terminal disclaimer be accompanied by a reply requesting reconsideration of the prior Office action. Even where the NSDP rejection is provisional the reply must be complete. See MPEP § 804, subsection I.B.1. For a reply to a non-final Office action, see 37 CFR 1.111(a). For a reply to final Office action, see 37 CFR 1.113(c). A request for reconsideration while not provided for in 37 CFR 1.113(c) may be filed after final for consideration. See MPEP §§ 706.07(e) and 714.13. The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The actual filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/apply/applying-online/eterminal-disclaimer. Claims 1-11 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-10 of U.S. Patent No. 12,233,179 B2. Although the claims at issue are not identical, they are not patentably distinct from each other because the scopes of the claims 1-11 in the pending application and the scopes of the claims 1-10 in the U.S. Patent No. 12,233,179 B2 are the same, but rewritten using similar words. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to MONZER R CHORBAJI whose telephone number is (571)272-1271. The examiner can normally be reached M-F 5:30-12:00 and 6:00-9:00. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Jill J Warden can be reached at (571)272-1267. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /MONZER R CHORBAJI/Primary Examiner, Art Unit 1799
Read full office action

Prosecution Timeline

Feb 13, 2025
Application Filed
Oct 21, 2026
Non-Final Rejection mailed — §102, §DOUBLEPATENT (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12779069
COMPOSITIONS AND METHODS FOR REDUCING BIOBURDEN IN CHROMATOGRAPHY
3y 4m to grant Granted Nov 03, 2026
Patent 12779439
SYSTEM FOR THE TREATMENT OF AN EXHAUST GAS OF A DIESEL COMBUSTION ENGINE
3y 1m to grant Granted Nov 03, 2026
Patent 12781022
POLYPROPYLENE COMPOSITION HAVING IMPROVED RADIATION STABILITY
2y 8m to grant Granted Nov 03, 2026
Patent 12766480
METHOD AND APPARATUS FOR INDUCTIVELY HEATING MICRO- AND MESO-CHANNEL PROCESS SYSTEMS
2y 1m to grant Granted Oct 20, 2026
Patent 12758936
COMPACT AND MAINTAINABLE WASTE REFORMATION APPARATUS
3y 0m to grant Granted Oct 13, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
76%
Grant Probability
98%
With Interview (+21.3%)
2y 6m (~10m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1221 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month